Recruiting NA Letrozole

Tests treatment safety and results for Letrozole

Official title The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET)

ClinicalTrials.gov ID: NCT06006091

What this study is testing

What is Letrozole?

Letrozole is an investigational medicine, being studied as a potential treatment for letrozole.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The goal of this single center, non-blinded, randomized controlled clinical trial to comparison of pregnancy outcomes and perinatal outcomes in patients undergoing IVF treatment (including ICSI) with FET with letrozole-induce endothelial preparation protocol versus natural cycles, hormone replacement protocol. The main questions it aims to answer are: To investigate whether letrozole-induce endothelial preparation is effective in improving the live birth rate and clinical pregnancy rate.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages up to 40, women only

You may be able to join if

  • Women \<40 years of age undergoing IVF or ICSI at our reproductive center with a total of ≤3 superovulation cycles , and with ≥2 cleavage embryos or...

You likely can't join if

  • Patients with chromosomal abnormalities in either spouse, hydrosalpinx, severe endometriosis, adenomyosis, and uterine and uterine cavity organic...
  • patients who underwent pre-implantation genetic diagnosis (PGT);
  • patients who underwent ICSI using surgically obtained epididymal or testicular spermatozoa;
  • patients with a Body mass index (BMI, = weight/height2 ) \> 30 kg/m2;
  • patients with recurrent spontaneous abortions;
  • patients with sequential embryo transfer.

The study team makes the final eligibility decision.

Where it's taking place

  • Shanghai, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, up to 40 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.